Related Experiment Videos
Plasma and brain methamphetamine concentrations in neonatal rats
1Division of Developmental Biology, Children's Hospital Research Foundation, Cincinnati, OH 45229-3039, USA.
Neurotoxicology and Teratology
|March 29, 2001
Summary
Neonatal methamphetamine (MA) exposure impacts brain development, causing learning deficits. However, internal drug doses in rats did not fully predict these long-term neurobehavioral effects.
Area of Science:
- Neuroscience
- Developmental Toxicology
- Pharmacology
Background:
- Neonatal exposure to D-methamphetamine (D-MA) is linked to altered neurodevelopment.
- Previous studies indicate D-MA can cause acoustic startle hyperreactivity and spatial learning deficits.
Purpose of the Study:
- To characterize the internal dose of D-MA in neonatal rats.
- To correlate pharmacokinetic parameters with observed neurobehavioral outcomes.
Main Methods:
- D-methamphetamine (MA) levels were measured in plasma and brain tissue of neonatal rats at different ages and dose schedules.
- Neurobehavioral tests, including the acoustic startle and Morris maze, were used to assess outcomes.
- Pharmacokinetic parameters (AUC) were analyzed in relation to age and dosing frequency.
Main Results:
- Brain concentrations of MA showed age-dependent effects, with higher AUC in rats treated on postnatal day 1 compared to day 11.
- Pharmacokinetic parameters did not consistently predict long-term spatial learning deficits or acoustic startle hyperreactivity.
- Observed plasma concentrations in rats are comparable to estimates for human methamphetamine abusers.
Conclusions:
- Neonatal D-MA exposure induces specific neurobehavioral changes, but internal dose metrics do not fully explain these effects.
- Age-dependent brain concentrations suggest differential vulnerability during early development.
- Findings provide context for human methamphetamine exposure risks.